Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis
Triptolide (TP), a major active component of Tripterygium wilfordii Hook.F. (TWHF), is used to treat rheumatoid arthritis (RA). However, it has a narrow therapeutic window due to its serious toxicities. To increase the therapeutic index, a new triptolide-loaded transdermal delivery system, named tri...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_539e3813f59f45d5aa69ec1eae6f3e01 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Gui Chen |e author |
700 | 1 | 0 | |a Baohua Hao |e author |
700 | 1 | 0 | |a Dahong Ju |e author |
700 | 1 | 0 | |a Meijie Liu |e author |
700 | 1 | 0 | |a Hongyan Zhao |e author |
700 | 1 | 0 | |a Zhongping Du |e author |
700 | 1 | 0 | |a Jizi Xia |e author |
245 | 0 | 0 | |a Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis |
260 | |b Elsevier, |c 2015-11-01T00:00:00Z. | ||
500 | |a 2211-3835 | ||
500 | |a 2211-3843 | ||
500 | |a 10.1016/j.apsb.2015.09.006 | ||
520 | |a Triptolide (TP), a major active component of Tripterygium wilfordii Hook.F. (TWHF), is used to treat rheumatoid arthritis (RA). However, it has a narrow therapeutic window due to its serious toxicities. To increase the therapeutic index, a new triptolide-loaded transdermal delivery system, named triptolide-loaded liposome hydrogel patch (TP-LHP), has been developed. In this paper, we used a micro-needle array to deliver TP-LHP to promote transdermal absorption and evaluated this treatment on the pharmacokinetics and pharmacodynamics of TP-LHP in a rat model of collagen-induced arthritis (CIA). The pharmacokinetic results showed that transdermal delivery of microneedle TP-LHP yielded plasma drug levels which fit a one-compartment open model. The relationship equation between plasma concentration and time was C=303.59×(e−0.064t−e−0.287t). The results of pharmacodynamic study demonstrated that TP-LHP treatment mitigated the degree of joint swelling and suppressed the expressions of fetal liver kinase-1, fetal liver tyrosine kinase-4 and hypoxia-inducible factor-1α in synovium. Other indicators were also reduced by TP-LHP, including hyperfunction of immune, interleukin-1β and interleukin-6 levels in serum. The therapeutic mechanism of TP-LHP might be regulation of the balance between Th1 and Th2, as well as inhibition of the expression and biological effects of vascular endothelial growth factor. | ||
546 | |a EN | ||
690 | |a Pharmacokinetics | ||
690 | |a Pharmacodynamics | ||
690 | |a Triptolide | ||
690 | |a Micro-electro-mechanical system | ||
690 | |a Microneedles | ||
690 | |a Collagen-induced arthritis | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Acta Pharmaceutica Sinica B, Vol 5, Iss 6, Pp 569-576 (2015) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2211383515001380 | |
787 | 0 | |n https://doaj.org/toc/2211-3835 | |
787 | 0 | |n https://doaj.org/toc/2211-3843 | |
856 | 4 | 1 | |u https://doaj.org/article/539e3813f59f45d5aa69ec1eae6f3e01 |z Connect to this object online. |